ArticleCancers2023

Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy.

Patrik Pöschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.